DRTS
Alpha Tau Medical Ltd. · Healthcare · Biotechnology
Last
$7.76
−$0.17 (−2.14%) 4:00 PM ET
Prev close $7.93
Open $7.86
Day high $7.88
Day low $7.60
Volume 203,576
Avg vol 376,756
Mkt cap
$661.65M
Sector
Healthcare
AI report sections
DRTS
Alpha Tau Medical Ltd.
No AI report section text found yet for this symbol.
Volume vs average
Intraday (cumulative)
−34% (Below avg)
Vol/Avg: 0.66×
RSI
59.68 (Neutral)
Neutral (40–60)
MACD momentum
Intraday
+0.00 (Strong)
MACD: 0.01 Signal: 0.01
Short-Term
+0.01 (Strong)
MACD: 0.32 Signal: 0.31
Long-Term
-0.01 (Weak)
MACD: 0.76 Signal: 0.77
Intraday trend score 54.00

Latest news

DRTS 12 articles Positive: 3 Neutral: 0 Negative: 0
Positive GlobeNewswire Inc. • Alpha Tau Medical Ltd.
Alpha Tau to Present at the J.P. Morgan 2026 Healthcare Conference

Alpha Tau Medical will present a corporate overview and update at the J.P. Morgan 2026 Healthcare Conference on January 15, 2026, discussing recent achievements and upcoming data milestones for their Alpha DaRT cancer therapy.

DRTS DRTSW healthcare cancer therapy oncology conference investor relations
Sentiment note

Company is presenting at a major healthcare conference, highlighting recent patient treatments and research progress in cancer therapy

Positive GlobeNewswire Inc. • N/A
Radiopharmaceuticals Market Products and Applications Report 2025 | SPECT Radiopharmaceuticals Lead Diagnostic Market with 67% Share

The global radiopharmaceuticals market is projected to grow at a CAGR of 10.3% from 2024 to 2030, driven by the increasing prevalence of chronic diseases, advancements in imaging technology, and the transition towards personalized medicine. North America and Asia-Pacific are the key regional markets.

ATNM DRTS DRTSW BAYRY radiopharmaceuticals SPECT PET diagnostics
Sentiment note

The article lists the company as one of the key global players in the radiopharmaceuticals market, suggesting its strong presence and potential for growth.

Positive GlobeNewswire Inc. • Globe Newswire
Alpha Tau Announces Appointment of Maya Netser to its Board of Directors; Board Member Meir Jakobsohn Stepping Down, Staying on as Advisor

Alpha Tau Medical Ltd. announced the appointment of Maya Netser to its Board of Directors, while Meir Jakobsohn is stepping down from the Board but will continue to serve as an advisor.

DRTS DRTSW Alpha Tau Medical Board of Directors Maya Netser Meir Jakobsohn
Sentiment note

The article announces the appointment of a new board member, Maya Netser, who is described as bringing a wealth of experience and a keen understanding of the industry. This suggests the company is taking steps to strengthen its leadership and position itself for future growth.

Unknown Zacks Investment Research • Zacks Equity Research
New Strong Buy Stocks for January 8th

TIMB, AKYA, DRTS, TRUP and QSG have been added to the Zacks Rank #1 (Strong Buy) List on January 8, 2024.

TRUP TIMB AKYA DRTS
Unknown Benzinga • Benzinga Insights
Expert Ratings for Alpha Tau Medical

Alpha Tau Medical (NASDAQ:DRTS) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 3 1 0 0 0 Last 30D 1 0 0 0 0 1M Ago 1 1 0 0 0 2M Ago 0 0 0 0 0 3M Ago 1 0 0 0 0 In the last 3 months, 4 analysts have offered 12-month price targets for Alpha Tau Medical. The company ...Full story available on Benzinga.com

DRTS Analyst Ratings
Unknown Zacks Investment Research • Zacks Equity Research
Down -20.29% in 4 Weeks, Here's Why You Should You Buy the Dip in Alpha Tau Medical Ltd. (DRTS)

Alpha Tau Medical Ltd. (DRTS) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

DRTS
Unknown Benzinga • Benzinga Insights
Analyst Ratings for Alpha Tau Medical

Within the last quarter, Alpha Tau Medical (NASDAQ:DRTS) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 2 2 0 0 0 Last 30D 0 1 0 0 0 1M Ago 0 0 0 0 0 2M Ago 1 0 0 0 0 3M Ago 1 1 0 0 0 According to 4 analyst offering 12-month price targets in the last 3 months, Alpha Tau Medical has ...Full story available on Benzinga.com

DRTS Analyst Ratings
Unknown Benzinga • Lisa Levin
Why Alpha Tau Medical Shares Are Trading Higher By Over 8%; Here Are 20 Stocks Moving Premarket

Gainers Tivic Health Systems, Inc. (NASDAQ: TIVC) rose 62.4% to $3.15 in pre-market trading after falling 11% on Monday. Tivic Health Systems inked a pact to make its products available on AmerisourceBergen’s third-party marketplace. Shineco, Inc. (NASDAQ: SISI) shares gained 50% to $0.2130 in pre-market trading after declining over 3% on Monday. noco-noco Inc. (NASDAQ: NCNC) shares rose 44.5% to $2.89 in pre-market trading after falling 23% on Monday. Caravelle International Group (NASDAQ: CACO) shares climbed 26.5% to $0.7087 in pre-market trading after falling 11% on Monday. iCoreConnect Inc. (NASDAQ: ICCT) shares gained 23.8% to $1.97 in pre-market trading after dipping 20% on Monday. Bright Scholar Education Holdings Limited (NYSE: BEDU) shares rose 14.7% to $1.01 in pre-market trading. Bright Scholar Education recently announced its unaudited financial results for ...

DRTS GNS HEI CACO News Penny Stocks Small Cap Pre-Market Outlook
Unknown Zacks Investment Research • Zacks Equity Research
What's in Store for Patterson Companies (PDCO) in Q4 Earnings?

Patterson Companies' (PDCO) fiscal fourth-quarter results are likely to reflect an improvement at the Animal Health segment.

PDCO MMSI HQY DRTS
Unknown Zacks Investment Research • Zacks Equity Research
Is a Beat Likely for Cooper Companies (COO) in Q2 Earnings?

Cooper Companies' (COO) fiscal second-quarter results are likely to reflect segmental strength.

COO SDC LVTX DRTS
Unknown Zacks Investment Research • Zacks Equity Research
Should You Buy Alpha Tau Medical (DRTS) Ahead of Earnings?

Alpha Tau Medical (DRTS) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

DRTS
Unknown Benzinga • Benzinga Insights
Benzinga's Top Ratings Upgrades, Downgrades For April 24, 2023

Upgrades For Medtronic PLC (NYSE:MDT), Barclays upgraded the previous rating of Equal-Weight to Overweight. Medtronic earned $1.30 in the third quarter, compared to $1.37 in the year-ago quarter. The stock has a 52-week-high of $114.22 and a 52-week-low of $75.77. At the end of the last trading period, Medtronic closed at $85.73. Loop Capital upgraded the previous rating for Trex Co Inc (NYSE:TREX) from Hold to Buy. For the fourth quarter, Trex Co had an EPS of $0.23, compared to year-ago quarter EPS of $0.55. The stock has a 52-week-high of $67.69 and a 52-week-low of $38.73. At the end of the last trading period, Trex Co closed at $53.66. According to Loop Capital, the prior rating for The AZEK Co Inc (NYSE:AZEK) was changed from Hold to Buy. In the first quarter, AZEK Co showed an EPS of $0.09, compared to $0.18 from the year-ago quarter. The stock has a 52-week-high of $30.26 and a 52-week-low of $15.15. At the end of the last trading period, AZEK Co closed at $26.70. Janney Montgomery Scott upgraded the previous rating for Synovus Financial Corp (NYSE:SNV) from Neutral to Buy. For the first quarter, Synovus Finl had an EPS of $1.33, compared to year-ago quarter EPS of $1.08. At the moment, the stock has a 52-week-high of $48.60 and a 52-week-low of $27.08. Synovus Finl closed at $30.99 at the end of the last trading period. For Healthpeak Properties Inc (NYSE:PEAK), Mizuho upgraded the previous rating of Neutral to Buy. Healthpeak Properties earned $0.44 in the fourth quarter, compared to $0.41 in the year-ago quarter. The current stock performance of Healthpeak Properties shows a 52-week-high of $35.71 and a 52-week-low of $20.21. Moreover, at the end of the last trading period, the closing price was at $21.13. According to B of A Securities, the prior rating for Ally Financial Inc (NYSE:ALLY) was changed from Underperform to Neutral. For the first quarter, Ally Financial had an EPS of $0.82, compared to year-ago quarter EPS of $2.03. At the moment, the stock has a 52-week-high of $45.38 and a 52-week-low of $21.59. Ally Financial closed at $25.86 at the end of the last trading period. According to Stifel, the prior rating for IDEAYA Biosciences Inc (NASDAQ:IDYA) was changed from Hold to Buy. For the fourth quarter, IDEAYA Biosciences had an EPS of $0.50, compared to year-ago quarter EPS of $0.47. At the moment, the stock has a 52-week-high of $19.13 and a 52-week-low of $8.14. IDEAYA Biosciences closed at $14.93 at the end of the last trading period. According to Wells Fargo, the prior rating for Medtronic PLC (NYSE:MDT) was changed from Equal-Weight to Overweight. Medtronic earned $1.30 in the third quarter, compared to $1.37 in the year-ago quarter. The current stock performance of Medtronic shows a 52-week-high of $114.22 and a 52-week-low of $75.77. Moreover, at the end of the last trading period, the closing price was at $85.73. According to Loop Capital, the prior rating for Alteryx Inc (NYSE:AYX) was changed from Hold to Buy. Alteryx earned $0.84 in the fourth quarter, compared to $0.17 in the year-ago quarter. The stock has a 52-week-high of $71.98 and a 52-week-low of $39.58. At the end of the last trading period, Alteryx closed at $52.13. According to JP Morgan, the prior rating for PPG Industries Inc (NYSE:PPG) was changed from Neutral to Overweight. For the first quarter, PPG Indus had an EPS of $1.82, compared to year-ago quarter EPS of $1.37. At the moment, the stock has a 52-week-high of $145.14 and a 52-week-low of $107.06. PPG Indus closed at $141.98 at the end of the last trading period. According to RBC Capital, the prior rating for Clearwater Paper Corp (NYSE:CLW) was changed from Sector Perform to Outperform. Clearwater Paper earned $0.30 in the fourth quarter, compared to $0.82 in the year-ago quarter. The stock has a 52-week-high of $46.40 and a 52-week-low of $26.21. At the end of the last trading period, Clearwater Paper closed at $32.67. See all analyst ratings upgrades. Downgrades According to Exane BNP Paribas, the prior rating for Microsoft Corp (NASDAQ:MSFT) was changed from Outperform to Neutral. In the second quarter, Microsoft showed an EPS of $2.32, compared to $2.48 from the year-ago quarter. At the moment, the stock has a 52-week-high of $294.18 and a 52-week-low of $213.46. Microsoft closed at $285.76 at the end of the last trading period. For First Solar Inc (NASDAQ:FSLR), Citigroup downgraded the previous rating of Neutral to Sell. For the fourth quarter, First Solar had an EPS of $0.07, compared to year-ago quarter EPS of $1.23. The current stock performance of First Solar shows a 52-week-high of $221.88 and a 52-week-low of $59.60. Moreover, at the end of the last trading period, the closing price was at $216.89. Wedbush downgraded the previous rating for Offerpad Solutions Inc (NYSE:OPAD) from Outperform to Neutral. In the fourth quarter, Offerpad Solutions showed an EPS of $0.50, compared to $0.11 from the year-ago quarter. The current stock performance of Offerpad Solutions shows a 52-week-high of $5.87 and a 52-week-low of $0.38. Moreover, at the end of the last trading period, the closing price was at $0.47. Wedbush downgraded the previous rating for Opendoor Technologies Inc (NASDAQ:OPEN) from Outperform to Neutral. For the fourth quarter, Opendoor Technologies had an EPS of $0.74, compared to year-ago quarter EPS of $0.13. At the moment, the stock has a 52-week-high of $8.37 and a 52-week-low of $0.92. Opendoor Technologies closed at $1.54 at the end of the last trading period. Truist Securities downgraded the previous rating for Insperity Inc (NYSE:NSP) from Buy to Hold. In the fourth ...Full story available on Benzinga.com

TNDM OPAD KRG ALLY Upgrades Downgrades Initiation Intraday Update
News and sentiment labels describe article tone and are provided for research purposes only. They are not trading recommendations or forecasts.
Trade Ranks, LLC is not a registered investment adviser or broker-dealer. All rankings and AI reports are for informational and educational purposes only and are not personalized advice. Investing involves risk. Policy Portal